Widely used type 2 diabetes medication metformin may be combined with antihypertensive drug syrosingopine to help fight cancer, reported a recent study. The drug cocktail that had adverse impact on the key functions of mitochondria destroyed tumor cells that require abundant energy for growth and metabolic activities.